Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

10 Pages (Click to Jump) V  « < 7 8 9 10   
 
  
Reply to this topic

IMC, IMMURON LIMITED
balance
post Posted: Sep 14 2004, 04:29 AM
  Quote Post


Posts: 5,636
Thanks: 625


In reply to: oldgolfer on Monday 13/09/04 09:05pm

G'day OG nice to hear from you.No, not an owner here as yet and yes they look OK.
Not much sex appeal but slow and steady wins the race.
I was a bit concerned about the TGA problems and the alleged nasties in Travelan as per the following article.Its a bit old now from mid August but must have had a few people worried at the time.

"Travelan, the anti-diarrhoea product belonging to Melbourne biotech Anadis, has been called in by the Therapeutic Goods Administration because it contains a potentially toxic substance.

Travelan was registered by the TGA in May and sales of the product were expected to begin in June.

Documents seen by The Age reveal that product contains Citrus x paradisi, an ingredient containing high levels of a toxic chemical, benzethonium chloride, which is commonly used as an industrial cleaner and disinfectant.

TGA spokeswoman Kay McNiece said after being alerted by The Age, Travelan was called in a month ago for the ingredient to be analysed.

"Before we could do anything they (Anadis) removed it from their product and they are producing an entirely new product now without that," she said. "In addition, the TGA is doing an audit of all products that contain Citrus x Paradisi to ensure that it is a proper herbal compound and not contaminated."


When asked on Friday why Travelan had not been sold in June, Anadis managing director Connor Graham said: "We just had, as always, a few last-minute delays. The product is being packaged right at the moment and it should be on the shelves in about three weeks' time."

Pictures of the Travelan packaging in Anadis' May newsletter show Citrus x Paradisi is listed as an ingredient.

When asked if Travelan contained Citrus x Paradisi, Mr Graham said the substance was simply a preservative used when running trials of Travelan.

"It was eliminated (from the product) because we felt that with the high level of antibody activity we have in it (Travelan), and the quality of the antibodies, we don't need a preservative in there."

When asked if the TGA recall of Travelan had anything to do with the Citrus x Paradisi being removed from Travelan, Mr Graham said: "It was one of the reasons why it was removed."

Mr Graham also admitted that Citrus x Paradisi was under investigation in Japan.

According to Anadis, chaired by Equity Trustee chairman Philip Molyneux, Travelan is the world's first protective drug to treat travellers' diarrhoea.

Documents lodged with the Australian Stock Exchange claim Travelan underwent "stringent double-blinded, placebo-controlled trials" in Europe and the US. "The trials showed protection of up to 90 per cent against infection with the type of E.coli that causes travellers' diarrhoea," the ASX was told.

Mr Graham said the company had spent up to $4 million on developing Travelan in recent times.

Ironically, Anadis had toyed with changing the name of Travelan to prevent it being confused with Travalcalm, the motion-sickness product manufactured by Pan Pharmaceuticals that triggered Australia's largest medical product recall in April last year.

Anadis is working with the Defence Department to develop an anthrax protection spray. The Federal Government has given Anadis $780,000 to develop the spray.

Anadis reported a $1.2 million net loss for the year to June 30, compared with a loss of $1.3 million a year earlier. The result was struck on revenue of $4.3 million.

Anadis shares closed 3 ¢ higher at 43 ¢ on Friday.





--------------------
Day Trader: Lowest form of life in the known universe.
Shorter: Can limbo under a day trader.
Investor: Salt of the Earth.Sits to the right of God (Warren Buffet)
Share prices are only ever manipulated down.
Paper losses are not really losses.
Chat site posters always know better & know more than anyone about anything.
I'm 29.
The cheque is in the mail.
 
oldgolfer
post Posted: Sep 13 2004, 08:05 PM
  Quote Post


Posts: 403
Thanks: 7



Greetings ANX holders and Balance Not sure if you are holding Balance but me thinks this is not the worst investment going around in the current market. Prefer it to Epitan myself; which is still a bit of a long shot to come off. These guys are going along nicely cant see them ever doing a big dive under.

lmaosmiley.gif

 
sandybeachs
post Posted: Sep 13 2004, 07:02 PM
  Quote Post


Posts: 710
Thanks: 4


hi guys.

light volume today

looks as thou it might go higher in the next few days

and possibly the next few weeks

i think shareholders are now waiting for the next announcement..

last price 45cents


Attached image(s)
Attached Image

 




--------------------
<span style='font-size:14pt;line-height:100%'>investors should seek pro advice</span>
 
sandybeachs
post Posted: Sep 11 2004, 10:31 AM
  Quote Post


Posts: 710
Thanks: 4


hi guys..

this is a very interesting story, which is still at it's early stages.

should things workout over the next 24months, we could see it's share price much higher than it is at present.

you can find plenty of good reading material (announcements) on it's website www.anadis.com.au.

also worth reading is a report from huntleys:http://www.anadis.com.au/admin/managedFiles/6/ConorSCG336.PDF

see below weekly chart, has been on a good rise for a number of weeks.

one would expect more positive news over the coming months that might help the share price


Attached image(s)
Attached Image

 




--------------------
<span style='font-size:14pt;line-height:100%'>investors should seek pro advice</span>
 
balance
post Posted: Jun 24 2004, 02:02 PM
  Quote Post


Posts: 5,636
Thanks: 625


Nice move today zenmammon on the back of the announcement on travelan.
As someone who travels to Asia fairly regularly i for one would swallow this stuff by the truck load to prevent travellers trots ruining the holiday / biz trip.
Used to refer to my hol's up there as temple and toilet tours. puke.gif




--------------------
Day Trader: Lowest form of life in the known universe.
Shorter: Can limbo under a day trader.
Investor: Salt of the Earth.Sits to the right of God (Warren Buffet)
Share prices are only ever manipulated down.
Paper losses are not really losses.
Chat site posters always know better & know more than anyone about anything.
I'm 29.
The cheque is in the mail.
 
zenmammon
post Posted: Jun 24 2004, 01:39 PM
  Quote Post


Posts: 62


This is one of the undiscovered gems of the Ozzie biotech market. They look after their capital while finding (hopefully) high volume markets for products with high margins. The 2006-2007 period should see the story really begin to unfold - Hopefully, because at end of day still speculative altho less so than many others out there.

I dont think people really value their scientific skill, just see them as an odd dairy product enhancer that needs to extract colostrum from cows - sounds rather primitive, doesnt it? The cow as a factory, but then Nature has created greater complexity than humans will ever be capable of. Slightly contradictory statement I know given that we are a part of Nature, nevertheless you get the idea, I'm sure.

 


balance
post Posted: Jun 7 2004, 04:32 PM
  Quote Post


Posts: 5,636
Thanks: 625


And a bit more .....
And hello to the old golfer !

Press Release Source: State Government of Victoria, Australia


Australian Scientists Isolate a Potential Anthrax Drug Lead and Attract The Attention of the US Defense Department
Sunday June 6, 6:30 pm ET


SAN FRANCISCO, June 6 /PRNewswire/ -- Once a deadly disease associated with animals, anthrax is now used as a bioterrorist weapon. While infection can be controlled with antibiotics, in a bioterrorism attack people will not know they have been infected until symptoms develop, at which stage drugs are useless.
With a world-wide focus on terrorism, scientists are hastily trying to develop both a diagnostic kit for the early detection of anthrax infection, and a drug that can prevent the disease from killing.

Scientists at La Trobe University in Melbourne, Australia, have developed a tool that has the potential to be as easy to use as a pregnancy test in the detection of anthrax. The technology has already attracted the attention of the US Defense Department.

The technology will be on show at BIO 2004, the world's biggest biotechnology convention to be held in San Francisco, June 6-9, 2004 where the group is seeking partners to further develop commercial potential.

There have been several incidences of anthrax use or potential use as a biological weapon in the last few years. In Japan a sect was implicated in a plan to produce and release anthrax into public spaces. Furthermore, the mailing of anthrax spores to U.S. Senate offices in the fall of 2001 resulted in the death of several postal workers.

If you breathe anthrax spores, and the infection takes hold, then you simply feel like you are getting the flu. At this stage antibiotics can protect you from developing the full-blown, and fatal, disease.

However, once the bacteria produces sufficient anthrax toxin, there is nothing that can be done to save the patient -- which is why anthrax is considered such a dangerous and destructive bioterrorism weapon.

For the first time scientists at La Trobe University have isolated a peptide, called T1, against Lethal Factor (LF) one of three proteins which comprise the anthrax toxin. After an anthrax spore enters the body and takes root, anthrax toxin can bind to cells of different parts of the body, including the skin, lungs or intestines via a 'receptor' - a protein on the surface of a cell that usually binds to some normal protein in the body. Once inside, LF acts like a pair of molecular shears, cutting an important protein, causing the cells to crash.

The technology including other novel libraries designed by scientists at the Cooperative Research Centre for Diagnostics - which will be discussed at BIO 2004 this week - has two target markets in the highly lucrative chase for a drug and test for anthrax:

(1) as a basis for a test, similar to a pregnancy test, that can detect
when anthrax has infected a patient (at present no such test exists);
and
(2) as a template for the pharmaceutical industry to develop drugs that
can kill or block the toxin once it is released in the body.


The La Trobe team, headed by molecular biologist Dr. Mick Foley, is working with researchers at CSIRO and the project is being carried out within the CRC for Diagnostics, of which La Trobe is a member.

The scientists have developed what Dr Foley calls "one of the best" collections of peptides and small protein markers that decorate the surface of bacterial viruses.

Dr. Foley says the system enables the researchers to pass millions of molecules over a desired target, for example the anthrax toxin LF, to find any that might bind tightly to it. "Which is how we found out target marker that binds to LF," he said.

The La Trobe T1 marker seems to bind to the business end of the toxin - the so-called 'active site' that the toxin uses to slice its protein target - binding to the anthrax toxin and disabling it before it can do damage.

In a similar way, molecules like T1 could be used to detect early infection by the bacteria or even the spores themselves. "We could imagine, for example, sampling the air around major sporting events that may be targets for bio-terrorists, like the Olympics, and using a peptide to sense the presence of these spores," Dr. Foley said.

"The test could give a colour signal if spores are detected and no colour if they are absent. Ultimately the test should be simple and cheap - a bit like a pregnancy test."

The potential of T1 to detect and kill anthrax bacteria, and the fact that T1 that can be synthesised cheaply, has triggered the interest of the US Department of Defense, according to Dr. Foley. Representatives from the US visited La Trobe laboratory recently to see first hand the potential of T1 and the other protein collections produces within the CRC for Diagnostics.







--------------------
Day Trader: Lowest form of life in the known universe.
Shorter: Can limbo under a day trader.
Investor: Salt of the Earth.Sits to the right of God (Warren Buffet)
Share prices are only ever manipulated down.
Paper losses are not really losses.
Chat site posters always know better & know more than anyone about anything.
I'm 29.
The cheque is in the mail.
 
oldgolfer
post Posted: Jun 7 2004, 01:25 PM
  Quote Post


Posts: 403
Thanks: 7



Davess, I,ve held these for 5 years and paid way more than current price. They seem to be tightly held, volume never large; I would wait for some weakness if it interests you but you may have to buy in parcels if you want a few; I am not a large holder. ohmy.gif

 
davesss
post Posted: Jun 7 2004, 11:57 AM
  Quote Post


Posts: 339
Thanks: 3


Hi all,

Interested in whether anyone follows this one??

Article today in the Australian:
Simple spray may foil anthrax
By Cameron Stewart
June 07, 2004
AUSTRALIAN and US bioterrorism experts believe research by a Melbourne-based company will lead to the world's first anti-anthrax spray, which can be used to protect troops and civilians from an anthrax attack.

The Defence Department is co-operating with the company, Anadis, to develop a spray that will offer immediate temporary protection against such bio-warfare.

The spray could be inhaled up to 48 hours before an expected anthrax attack to temporarily neutralise the agent until a suitable antibiotic can be administered.

The technology will be showcased at the world's biggest biotechnology conference, BIO 2004, beginning in San Francisco today.

Four premiers – Peter Beattie (Queensland), Bob Carr (NSW), Steve Bracks (Victoria) and Mike Rann (South Australia) – signed an agreement at the conference to jointly market their biotechnology capabilities.

If the spray is successfully developed, it could create an export market worth millions of dollars because of growing concerns about the likelihood of bioterrorist attacks on western nations.

Any effective anti-anthrax spray would also be of interest to the military.

Both the Australian Defence Force and the US military have experienced problems with the current anti-anthrax vaccines, which have caused serious side-effects to some troops.

At present, once a victim breathes anthrax and the agent produces sufficient toxin, there is nothing that can be done to save the person's life.

Anadis has patented a technology to isolate fragments of the antibodies.

The federal Government is giving $780,000 to help develop the spray, which has already attracted the attention of one of the US's key biodefence research institutes, the Mid-Atlantic Regional Centre of Excellence in Biodefence and Emerging Infectious Diseases.

Mr Bracks is expected to announce at the conference today that scientists at La Trobe University have developed a tool that could lead to the early detection of anthrax infection.

Such technology, if developed successfully, could allow anthrax victims to seek medical help before symptoms develop, by which stage drugs are useless.

Anthrax has been used in several acts of bioterrorism, including when a sect in Japan pumped the bacteria into a Toyko factory and when anthrax spores were mailed to the US Senate and media outlets after the September 11 attacks, killing postal workers.

Mick Foley, the molecular biologist heading up the La Trobe team, said the early detection technology would work like a pregnancy test. "The test could give a colour signal if anthrax spores are detected and no colour if they are absent," he said.

"Ultimately the test should be simple and cheap – a bit like a pregnancy test."


http://www.theaustralian.news.com.au/commo...5E31477,00.html

 
 


10 Pages (Click to Jump) V  « < 7 8 9 10

Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING